Hematology/Oncology
Llovet JM, Cappuyns S, Finn RS. HIMALAYA Overall Survival Prominence and Other Routes to the Peak-Reply. JAMA Oncol. 2024 Jan 11. doi: 10.1001/jamaoncol.2023.6271. Epub ahead[...]
Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee[...]
Friedman CF, D'Souza A, Bello Roufai D, Tinker AV, de Miguel M, Gambardella V, Goldman J, Loi S, Melisko ME, Oaknin A, Spanggaard I, Shapiro[...]
Seitz KP, Baclig NV, Stiller R, Chen A. Implementation of a Near-Peer Support Program to Improve Trainee Well-Being after Patient Safety Events. ATS Sch. 2023[...]
Pant S, Wainberg ZA, Weekes CD, Furqan M, Kasi PM, Devoe CE, Leal AD, Chung V, Basturk O, VanWyk H, Tavares AM, Seenappa LM, Perry[...]
Glaspy J, Bondarenko I, Krasnozhon D, Rutty D, Chen J, Fu Y, Wang S, Hou Q, Li S. Efbemalenograstim alfa not inferior to pegfilgrastim in[...]
Brauer ER, Ganz PA. History and current status of the survivorship care program at the University of California, Los Angeles Jonsson Comprehensive Cancer Center (UCLA[...]
Oluwole OO, Forcade E, Muñoz J, de Guibert S, Vose JM, Bartlett NL, Lin Y, Deol A, McSweeney P, Goy AH, Kersten MJ, Jacobson CA,[...]
Winston DJ, Young PA, Schlamm HT, Schiller GJ. Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host. Clin Infect[...]
Baclig NV, McCann KE. Updates in the treatment of HR+HER2- breast cancer. Curr Opin Obstet Gynecol. 2024 Feb 1;36(1):57-63. doi: 10.1097/GCO.0000000000000925. Epub 2023 Dec 7.[...]